AAAAAA
Results:
1-23
|
Results: 23
Authors:
Aronow, BJ
Toyokawa, T
Canning, A
Haghighi, K
Delling, U
Kranias, E
Molkentin, JD
Dorn, GW
Citation: Bj. Aronow et al., Divergent transcriptional responses to independent genetic causes of cardiac hypertrophy, PHYSIOL GEN, 6(1), 2001, pp. 19-28
Authors:
Molkentin, JD
Dorn, GW
Citation: Jd. Molkentin et Gw. Dorn, Cytoplasmic signaling pathways that regulate cardiac hypertrophy, ANN R PHYSL, 63, 2001, pp. 391-426
Authors:
Chen, L
Hahn, H
Wu, GY
Chen, CH
Liron, T
Schechtman, D
Cavallaro, G
Banci, L
Guo, YR
Bolli, R
Dorn, GW
Mochly-Rosen, D
Citation: L. Chen et al., Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC, P NAS US, 98(20), 2001, pp. 11114-11119
Authors:
Rogers, JH
Tsirka, A
Kovacs, A
Blumer, KJ
Dorn, GW
Muslin, AJ
Citation: Jh. Rogers et al., RGS4 reduces contractile dysfunction and hypertrophic gene induction in G(alpha q) overexpressing mice, J MOL CEL C, 33(2), 2001, pp. 209-218
Authors:
Haghighi, K
Schmidt, AG
Hoit, B
Brittsan, AG
Yatani, A
Lester, JW
Zhai, J
Kimura, Y
Dorn, GW
MacLennan, DH
Kranias, EG
Citation: K. Haghighi et al., Superinhibition of sarcoplasmic reticulum function by phospholamban induces cardiac contractile failure, J BIOL CHEM, 276(26), 2001, pp. 24145-24152
Authors:
Sato, Y
Kiriazis, H
Yatani, A
Schmidt, AG
Hahn, H
Ferguson, DG
Sako, H
Mitarai, S
Honda, R
Mesnard-Rouiller, L
Frank, KF
Beyermann, B
Wu, GY
Fujimori, K
Dorn, GW
Kranias, EG
Citation: Y. Sato et al., Rescue of contractile parameters and myocyte hypertrophy in calsequestrin overexpressing myocardium by phospholamban ablation, J BIOL CHEM, 276(12), 2001, pp. 9392-9399
Authors:
Dorn, GW
Citation: Gw. Dorn, Calcineurin inhibition in hypertrophy - Back from the dead!, CIRCULATION, 104(1), 2001, pp. 9-11
Authors:
Dash, R
Kadambi, VJ
Schmidt, AG
Tepe, NM
Biniakiewicz, D
Gerst, MJ
Canning, AM
Abraham, WT
Hoit, BD
Liggett, SB
Lorenz, JN
Dorn, GW
Kranias, EG
Citation: R. Dash et al., Interactions between phospholamban and beta-adrenergic drive may lead to cardiomyopathy and early mortality, CIRCULATION, 103(6), 2001, pp. 889-896
Authors:
Wang, XJ
Osinska, H
Dorn, GW
Nieman, M
Lorenz, JN
Gerdes, AM
Witt, S
Kimball, T
Gulick, J
Robbins, J
Citation: Xj. Wang et al., Mouse model of desmin-related cardiomyopathy, CIRCULATION, 103(19), 2001, pp. 2402-2407
Authors:
Robbins, J
Dorn, GW
Citation: J. Robbins et Gw. Dorn, Listening for hoof beats in heart beats, NAT MED, 6(9), 2000, pp. 968-970
Authors:
Dorn, GW
Tepe, NM
Wu, GY
Yatani, A
Liggett, SB
Citation: Gw. Dorn et al., Mechanisms of impaired beta-adrenergic receptor signaling in G(alpha q)-mediated cardiac hypertrophy and ventricular dysfunction, MOLEC PHARM, 57(2), 2000, pp. 278-287
Authors:
Wu, GY
Toyokawa, T
Hahn, H
Dorn, GW
Citation: Gy. Wu et al., epsilon Protein kinase C in pathological myocardial hypertrophy - Analysisby combined transgenic expression of translocation modifiers and G alpha(q), J BIOL CHEM, 275(39), 2000, pp. 29927-29930
Authors:
Wagoner, LE
Craft, LL
Singh, B
Suresh, DP
Zengel, PW
McGuire, N
Abraham, WT
Chenier, TC
Dorn, GW
Liggett, SB
Citation: Le. Wagoner et al., Polymorphisms of the beta(2)-adrenergic receptor determine exercise capacity in patients with heart failure, CIRCUL RES, 86(8), 2000, pp. 834-840
Authors:
De Windt, LJ
Lim, HW
Taigen, T
Wencker, D
Condorelli, G
Dorn, GW
Kitsis, RN
Molkentin, JD
Citation: Lj. De Windt et al., Calcineurin-mediated hypertrophy protects cardiomyocytes from apoptosis invitro and in vivo - An apoptosis-independent model of dilated heart failure, CIRCUL RES, 86(3), 2000, pp. 255-263
Authors:
Mochly-Rosen, D
Wu, GY
Hahn, H
Osinska, H
Liron, T
Lorenz, JN
Yatani, A
Robbins, J
Dorn, GW
Citation: D. Mochly-rosen et al., Cardiotrophic effects of protein kinase C epsilon - Analysis by in vivo modulation of PKC epsilon translocation, CIRCUL RES, 86(11), 2000, pp. 1173-1179
Authors:
Liggett, SB
Tepe, NM
Lorenz, JN
Canning, AM
Jantz, TD
Mitarai, S
Yatani, A
Dorn, GW
Citation: Sb. Liggett et al., Early and delayed consequences of beta(2)-adrenergic receptor overexpression in mouse hearts - Critical role for expression level, CIRCULATION, 101(14), 2000, pp. 1707-1714
Authors:
Dorn, GW
Brown, JH
Citation: Gw. Dorn et Jh. Brown, Gq signaling in cardiac adaptation and maladaptation, TREND CARD, 9(1-2), 1999, pp. 26-34
Authors:
Dorn, GW
Souroujon, MC
Liron, T
Chen, CH
Gray, MO
Zhou, HZ
Csukai, M
Wu, GY
Lorenz, JN
Mochly-Rosen, D
Citation: Gw. Dorn et al., Sustained in vivo cardiac protection by a rationally designed peptide thatcauses epsilon protein kinase C translocation, P NAS US, 96(22), 1999, pp. 12798-12803
Authors:
Dorn, GW
Tepe, NM
Lorenz, JN
Koch, WJ
Liggett, SB
Citation: Gw. Dorn et al., Low- and high-level transgenic expression of beta(2)-adrenergic receptors differentially affect cardiac hypertrophy and function in G alpha q-overexpressing mice, P NAS US, 96(11), 1999, pp. 6400-6405
Authors:
Yatani, A
Frank, K
Sako, H
Kranias, EG
Dorn, GW
Citation: A. Yatani et al., Cardiac-specific overexpression of G alpha q alters excitation-contractioncoupling in isolated cardiac myocytes, J MOL CEL C, 31(7), 1999, pp. 1327-1336
Authors:
Sah, VP
Minamisawa, S
Tam, SP
Wu, TH
Dorn, GW
Ross, J
Chien, KR
Brown, JH
Citation: Vp. Sah et al., Cardiac-specific overexpression of RhoA results in sinus and atrioventricular nodal dysfunction and contractile failure, J CLIN INV, 103(12), 1999, pp. 1627-1634
Authors:
Small, K
Feng, JF
Lorenz, J
Donnelly, ET
Yu, A
Im, MJ
Dorn, GW
Liggett, SB
Citation: K. Small et al., Cardiac specific overexpression of transglutaminase II (G(h)) results in aunique hypertrophy phenotype independent of phospholipase C activation, J BIOL CHEM, 274(30), 1999, pp. 21291-21296
Authors:
Tepe, NM
Lorenz, JN
Yatani, A
Dash, R
Kranias, EG
Dorn, GW
Liggett, SB
Citation: Nm. Tepe et al., Altering the receptor-effector ratio by transgenic overexpression of type V adenylyl cyclase: Enhanced basal catalytic activity and function without increased cardiomyocyte beta-adrenergic signalling, BIOCHEM, 38(50), 1999, pp. 16706-16713
Risultati:
1-23
|